Member Exclusive

New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition

This research article, brought to MedChemNet users free by our sister journal Future Medicinal Chemistry, discusses neurogenic agents as potentially innovative new drugs for the treatment of Alzheimer’s disease.

Go to the profile of MedChemNet
Aug 02, 2016

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.